HHS Doubts Benefit of Gender-Affirming Care for Children (2)

May 1, 2025, 12:37 PM UTCUpdated: May 1, 2025, 8:42 PM UTC

Gender-affirming care for children is under heightened scrutiny by the Trump administration in a US Department of Health and Human Services review of treatment.

The HHS review released Thursday finds “very weak evidence of benefit” of medical interventions for adolescents and children with gender dysphoria, according to a statement from the department. The review, the HHS said, “makes clear” that evidence doesn’t support medical intervention for children.

“Our duty is to protect our nation’s children—not expose them to unproven and irreversible medical interventions,” Jay Bhattacharya, director of the HHS’ National Institutes of Health, said in a statement.

“We must follow ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.